Irritable Bowel Syndrome (IBS) Treatment Market is expected to reach US$ 4,600.30 Mn by 2028

1
Irritable Bowel Syndrome (IBS) Treatment Market 
Irritable Bowel Syndrome (IBS) Treatment Market
Forecast to 2028 - COVID-19 Impact and Global
Analysis By Type IBS with Diarrhea (IBS-D), IBS
with Constipation (IBS-C), and Mixed IBS
(IBS-M), Product (Rifaximin, Eluxadoline,
Lubiprostone, Linaclotide, and Others), and
Distribution Channel (Hospital Pharmacies, Drug
Stores and Retail Pharmacies, and Online
Pharmacies)
2
Current and future Market Scenario
Irritable Bowel Syndrome (IBS) Treatment Market 

• According to our new market research study on
  Irritable Bowel Syndrome (IBS) Treatment Market
  to 2028 Global Analysis and Forecast by Type,
  Treatment, and End User, the market was valued
  at US 2,153.89 million in 2020 and is projected
  to reach US 4,600.30 million by 2028 it is
  expected to grow at a CAGR of 10.1 from 2021 to
  2028.
• Based on type, the irritable bowel syndrome (IBS)
  treatment market is segmented into mixed IBS
  (IBS-M), IBS with diarrhea (IBS-D), and IBS with
  constipation (IBS-C). The mixed IBS (IBS-M)
  segment held the largest share of the market in
  2020. Also, the same segment is expected to
  register the highest CAGR during 20212028. In
  the coming years, the rising prevalence of IBS
  among women and men is anticipated to propel the
  demand for the medicines that can treat combined
  symptoms of constipation and diarrhea.

3
Market Segments
Irritable Bowel Syndrome (IBS) Treatment Market   
By Product Rifaximin Eluxadoline Linaclotide Lubip
rostone Others
By Type IBS with Diarrhea (IBS-D) IBS with
Constipation (IBS-C) Mixed IBS (IBS-M)
By Distribution Channel Hospitals Pharmacies Drug
Stores and Retail Pharmacies Online Pharmacies
4
Leading Players
Irritable Bowel Syndrome (IBS) Treatment Market  
Company Profiles in Irritable Bowel Syndrome
(IBS) Treatment Market are Ironwood
Pharmaceuticals, Inc. AbbVie. Sebela
Pharmaceuticals, Inc. Takeda Pharmaceutical
Company Limited Alfasigma S.p.A. Astellas Pharma
Inc. AstraZeneca Synthetic Biologics, Inc. Bausch
Lomb Incorporated Lannett Company Inc
5
Irritable Bowel Syndrome (IBS) Treatment
Market  
Access Full Research Report at
https//www.theinsightpartners.com/reports/irritab
le-bowel-syndrome-treatment-market
Thank You!

• Thank You!